Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.01.006Source: DataRank Database

Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor is a research paper published in Clinical Gastroenterology and Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: hybridTopics (32)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

María T. Abreu ORCID,Sarah N. Flier,Konstantinos Papamichael ORCID,Florian Rieder ORCID,Mark S. Silverberg ORCID

Live enrichment

PubMed:33421628 PMC:PMC8257758

Israel National Road Safety Authority

Grant: 5T32DK007760-18

Research Training in Gastroenterology

Crohn's & Colitis Foundation

Grant: 569125

NIDDK NIH HHS

Grant: P30 DK120515

NIDDK NIH HHS

Grant: R01 DK123233

NIDDK NIH HHS

Grant: T32 DK007760

Shire

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5P30DK120515-04

San Diego Digestive Diseases Research Center

American Gastroenterological Association

National Institutes of Health

hybridLicense: cc-by-nc-nd

publisherhttp://www.cghjournal.org/article/S1542356521000082/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1542356521000082?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356521000082?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8257758

repositoryhttps://escholarship.org/uc/item/6nb4g390

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansInflammatory Bowel DiseasesAutoantibodiesDrug MonitoringGenome-Wide Association StudyAdalimumabInfliximabTumor Necrosis Factor Inhibitors

Keywords

ImmunologyClinical Sciences610Autoimmune Disease616HumansAutoantibodiesBiomedical and Clinical SciencesGastroenterology & HepatologyInflammatory and immune systemInflammatory Bowel DiseaseAdalimumabInflammatory Bowel DiseasesInfliximabGood Health and Well Being5.1 PharmaceuticalsImmunizationTumor Necrosis Factor InhibitorsDrug MonitoringDigestive DiseasesBiotechnologyGenome-Wide Association Study

Sustainable Development Goals

SDG 3: 3. Good health